Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014Marc Scherlinger, Laurent Arnaud, Philippe Mertz et al.|Autoimmunity Reviews|2020Cited by 153
Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesRenaud Felten, Laurent Arnaud, Maxime Dubois et al.|The Lancet Rheumatology|2021Cited by 125
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patientsFrançois Danion, Christelle Sordet, Ghada Alsaleh et al.|RMD Open|2017Cited by 29
Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseasesRenaud Felten, Laurent Arnaud, Maxime Dubois et al.|Lara D. Veeken|2021Cited by 29
B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologicsRenaud Felten, Jacques‐Eric Gottenberg, Pierre‐Marie Duret et al.|Annals of the Rheumatic Diseases|2021Cited by 20